Hyperaldosteronism, unspecified
ICD-10 E26.9 is a billable code used to indicate a diagnosis of hyperaldosteronism, unspecified.
Hyperaldosteronism is a condition characterized by excessive production of aldosterone, a hormone produced by the adrenal glands that regulates sodium and potassium levels, as well as blood pressure. This condition can lead to hypertension, hypokalemia, and metabolic alkalosis. The unspecified designation indicates that the specific cause of hyperaldosteronism has not been determined, which may include primary causes such as adrenal adenoma or hyperplasia, or secondary causes related to conditions like heart failure or renal artery stenosis. Patients may present with symptoms such as muscle weakness, fatigue, and increased thirst. Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and conducting imaging studies of the adrenal glands. Treatment options may include mineralocorticoid receptor antagonists, surgical intervention, or management of underlying conditions. Accurate coding is essential for proper treatment and reimbursement, as well as for tracking the prevalence and outcomes of this endocrine disorder.
Detailed patient history, lab results, imaging studies, and treatment plans must be documented.
Patients presenting with hypertension and hypokalemia, or those with adrenal masses.
Endocrinologists should ensure that all relevant lab values and imaging results are included in the documentation to support the diagnosis.
Documentation of renal function tests and any related renal conditions that may contribute to secondary hyperaldosteronism.
Patients with renal artery stenosis presenting with hypertension.
Nephrologists should document the relationship between renal function and aldosterone levels to clarify the diagnosis.
Used to confirm diagnosis of hyperaldosteronism.
Document the reason for the test and the results.
Endocrinologists should ensure that the test is performed under appropriate conditions to avoid false results.
Primary hyperaldosteronism is caused by adrenal gland disorders, such as adenomas or hyperplasia, while secondary hyperaldosteronism is due to external factors like renal artery stenosis or heart failure affecting aldosterone production.
